NYSE:BSXMedical Equipment
Boston Scientific (BSX) Q1 EPS Surge Tests Sustainability Of Bullish Growth Narratives
Boston Scientific (BSX) opened 2026 with Q1 revenue of US$5.2b and basic EPS of US$0.90, alongside trailing 12 month EPS of US$2.41 on revenue of US$20.6b that sits against a 75.4% jump in earnings over the past year. Over recent quarters the company has seen revenue move from US$4.7b in Q1 2025 to around US$5.2b in Q1 2026, while quarterly EPS has ranged from roughly US$0.46 to US$0.90. This sets up a picture of expanding profitability supported by a higher net margin.
See our full analysis...